within Pharmacolibrary.Drugs.ATC.S;

model S03CA04
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 2.5e-05,
    adminDuration  = 600,
    adminMass      = 5 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.005,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>S03CA04</td></tr><td>route:</td><td>ophthalmic</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Combination preparation containing hydrocortisone (a corticosteroid with anti-inflammatory and immunosuppressive properties) together with antiinfective agents, used for ophthalmic purposes such as conjunctivitis or other inflammatory and infective conditions of the eye. It is currently in use in some countries for ophthalmic application.</p><h4>Pharmacokinetics</h4><p>No published pharmacokinetic studies reporting parameters for hydrocortisone and antiinfectives combination under ATC S03CA04 have been identified. Parameters below represent an estimated single-compartment model for topical ophthalmic administration in adults, based on reported pharmacokinetics of hydrocortisone alone.</p><h4>References</h4><ol><li><p>Rakusin, W (1972). Traumatic hyphema. <i>American journal of ophthalmology</i> 74(2) 284–292. DOI:<a href=\"https://doi.org/10.1016/0002-9394(72)90546-6\">10.1016/0002-9394(72)90546-6</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/5054238/\">https://pubmed.ncbi.nlm.nih.gov/5054238</a></p></li><li><p>Reinberg, A (1992). Circadian changes in psychologic effects of ethanol. <i>Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology</i> 7(2) 149–156. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/1418304/\">https://pubmed.ncbi.nlm.nih.gov/1418304</a></p></li><li><p>Atiia, MA, &amp; Ivanova, LA (1978). [Pharmacokinetic study of ophthalmic ointments of hydrocortisone acetate in combination with sodium sulfapyridazine]. <i>Farmatsiia</i> 27(5) 28–30. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/700179/\">https://pubmed.ncbi.nlm.nih.gov/700179</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end S03CA04;
